Step 1 Biochemistry
Biochemistry on USMLE Step 1 spans molecular biology, metabolism, and genetics — roughly 15–20% of the exam and one of the most frequently tested subjects in the basic sciences. Molecular topics like DNA replication, transcription, and translation are tested through mechanism questions: which enzyme does what, which drug hits which target, what happens when a step fails. Metabolism questions lean heavily on pathway integration — you need to know not just individual reactions but how pathways talk to each other across fed and fasted states. If you are searching for high-yield biochemistry topics for Step 1, start with the pathway pairs that examiners love to swap.
Most questions embed biochemistry into clinical vignettes. A child with recurrent hypoglycemia after fasting, a non-ketotic presentation, and hepatomegaly is a glycogen storage disease question dressed as pediatrics. A patient with neuropsychiatric symptoms, liver disease, and Kayser-Fleischer rings is testing copper metabolism. Recognizing the biochemical defect from clinical clues is the skill being tested, not just memorizing enzyme names. Students consistently confuse OTC deficiency with CPS I deficiency because both elevate ammonia — but only OTC also elevates orotic acid, a detail that decides the question.
The hardest part of USMLE biochemistry is keeping similar pathways straight. Beta-oxidation vs fatty acid synthesis, purine vs pyrimidine metabolism, NER vs BER — these pairs are deliberately confusable. Another common misconception: students assume that muscle can release glucose into the blood via glycogenolysis, but muscle lacks glucose-6-phosphatase, so that pathway is liver-only. Directionality errors (which strand is template, which way kinesin moves, which parent contributes the imprinted allele) round out the highest-yield Step 1 metabolism mistakes. Build your mental models clearly and stress-test them with the specific confusions that recur on the exam.
Nucleotide and Nucleic Acid Structure
Purines vs pyrimidines, base pairing hydrogen bonds, and how GC content affects DNA melting temperature.
- Confuses which base class has the larger bicyclic ring structure
- Reverses the number of hydrogen bonds in A-T vs G-C base pairs
DNA Replication
Enzyme order at the replication fork, leading vs lagging strand logic, and telomerase cancer relevance.
- Miscounts parental strand retention after two rounds of semiconservative replication
- Confuses primase's primer-synthesis role with DNA pol III's elongation role
DNA Repair Pathways
Each repair pathway maps to a specific lesion type, with diseases revealing which pathway is broken.
- Confuses NER and BER by swapping the lesion types each pathway handles
- Misattributes xeroderma pigmentosum to mismatch repair rather than NER
Mutations and Their Consequences
Frameshift, nonsense, and missense mutations ranked by severity, with classic disease examples for each.
- Confuses silent mutations with conservative missense mutations
- Underestimates the severity of frameshift mutations relative to point substitutions
Transcription (RNA Synthesis)
RNA polymerase types, promoter elements, and which drugs target prokaryotic vs eukaryotic polymerases.
- Confuses the promoter (RNA pol binding site) with the operator (repressor binding site)
- Misassigns rRNA synthesis to RNA pol II instead of RNA pol I
Eukaryotic RNA Processing
Pre-mRNA modifications, spliceosome mechanics, and the autoimmune antibodies that target snRNPs.
- Confuses the timing and location of 5' cap vs poly-A tail addition
- Reverses which sequences (introns vs exons) are removed by the spliceosome
Translation (Protein Synthesis)
Ribosome sites, antibiotic targets by subunit, start/stop codon mechanics, and wobble base pairing.
- Mislocates peptide bond formation to the A site rather than the P site
- Missing that AUG loss completely abolishes translation initiation rather than just shifting the reading frame
Genetic Code Properties
Degeneracy at the third codon position, single-codon amino acids, and mitochondrial code exceptions.
- Misses that codon degeneracy is primarily at the third position
- Overlooks mitochondrial exceptions to the standard genetic code
Gene Expression Regulation (Pro + Eukaryotes)
Lac operon dual control, trp operon repression logic, and histone acetylation effects on transcription.
- Misses the dual requirement of lactose presence AND glucose absence for maximal lac operon expression
- Reverses the logic of the trp operon, thinking high tryptophan induces rather than represses it
Chromosome Organization and Imprinting
Nucleosome histone octamer composition and parental origin rules in Prader-Willi vs Angelman syndrome.
- Incorrectly includes H1 in the nucleosome core octamer instead of H2A, H2B, H3, H4
- Reverses the parental origin of the deleted chromosome 15 in Prader-Willi vs Angelman syndrome
Cell Cycle and Regulation
Cyclin-CDK complexes, checkpoint regulators, Rb/E2F logic, and the two-hit hypothesis for tumor suppressors.
- Confuses reversible G0 quiescence with permanent cell cycle exit
- Confuses which partner (cyclin vs CDK) oscillates to drive cycle progression
Organelle Functions
Protein trafficking decisions, mannose-6-phosphate lysosomal targeting, and peroxisomal vs mitochondrial oxidation.
- Confuses free ribosome vs RER destinations for newly synthesized proteins
- Misses the mannose-6-phosphate tagging step required for lysosomal targeting
Cytoskeleton
Kinesin vs dynein directionality, intermediate filament tumor markers, and taxane vs vinca alkaloid mechanisms.
- Inverts kinesin and dynein directionality on microtubules
- Confuses taxane mechanism (stabilize) with vinca alkaloid mechanism (depolymerize)
Membrane Transport
Na/K ATPase stoichiometry, GLUT vs SGLT transporter distribution, and intestinal glucose absorption polarity.
- Misremembers Na/K ATPase stoichiometry as 2:2 rather than 3 Na out / 2 K in
- Confuses GLUT2 (pancreatic sensor) with GLUT4 (insulin-regulated muscle/fat transporter)
Cellular Signaling Pathways
GPCR second messenger cascades (Gs/Gi/Gq), RTK dimerization, and JAK-STAT pathway ligands.
- Inverts Gs and Gi effects on adenylyl cyclase and cAMP levels
- Confuses Gq second messenger pathway (IP3/DAG/Ca2+) with Gs cAMP pathway
Collagen Synthesis
Sequential collagen synthesis steps, type-to-tissue matching, and disease mapping to specific synthesis defects.
- Confuses vitamin C (required for collagen hydroxylation) with vitamin K
- Inverts the order of collagen types in wound healing (type III early, type I late)
Elastin
Fibrillin scaffolding for elastin, Marfan syndrome mechanism, and how A1AT deficiency destroys lung tissue.
- Confuses the fibrillin-1 scaffold defect in Marfan syndrome with a primary elastin defect
- Misses that A1AT deficiency causes emphysema indirectly via uninhibited elastase, not direct elastin loss
PCR (Polymerase Chain Reaction)
Denaturation-annealing-extension cycle logic, Taq polymerase properties, and qPCR vs standard PCR distinction.
- Incorrectly attributes proofreading exonuclease activity to Taq polymerase
- Confuses standard PCR (qualitative) with qPCR (quantitative real-time measurement)
Southern, Northern, and Western Blots
Southern detects DNA, Northern detects RNA, Western detects protein — probe vs antibody detection matters.
- Inverts Northern (RNA) and Western (protein) blot targets
- Confuses nucleic acid probe detection (Southern/Northern) with antibody detection (Western)
ELISA and Flow Cytometry
Two-antibody sandwich ELISA design, flow cytometry for cell marker quantification, and HIV antibody detection timing.
- Misses that sandwich ELISA requires two antibodies (capture + detection) flanking the antigen
- Confuses flow cytometry (quantitative marker detection) with microscopy (morphologic visualization)
CRISPR and Gene Therapy Concepts
Guide RNA directs Cas9 cutting, with NHEJ vs HDR determining whether edits are precise or error-prone.
- Confuses NHEJ (default, error-prone) with HDR (precise, template-dependent) as the default CRISPR repair outcome
- Underestimates the role of guide RNA in directing Cas9 to the target locus
Karyotyping and FISH
Karyotyping detects large chromosomal changes; FISH resolves microdeletions and translocations karyotyping misses.
- Overestimates karyotype resolution, believing it can detect microdeletions detectable only by FISH
- Limits FISH utility to deletions only, missing its role in diagnosing chromosomal translocations
Inheritance Patterns
Pedigree pattern recognition across AD, AR, X-linked, and mitochondrial inheritance, including codominance vs incomplete dominance.
- Assumes X-linked recessive carrier females are always phenotypically normal, ignoring skewed X-inactivation
- Confuses mitochondrial inheritance with autosomal dominant by assuming paternal transmission is possible
Genetic Terms and Concepts
Penetrance vs expressivity, dominant negative vs haploinsufficiency, and when uniparental disomy actually causes disease.
- Conflates penetrance (who is affected) with expressivity (how severely they are affected)
- Confuses haploinsufficiency (insufficient product) with dominant negative (mutant product actively inhibits normal product)
Hardy-Weinberg Principle
Calculating carrier frequency (2pq) from disease prevalence requires not confusing q² with q.
- Confuses disease frequency (q²) with allele frequency (q) when applying Hardy-Weinberg to AR disorders
- Uses q² instead of 2pq to estimate carrier frequency, dramatically underestimating how common carriers are
Trinucleotide Repeat Disorders
Repeat expansion disorders, anticipation mechanism, Huntington toxic gain-of-function, and Fragile X premutation rules.
- Attributes anticipation to epigenetic changes rather than trinucleotide repeat expansion during meiosis
- Misclassifies Huntington disease as loss-of-function rather than toxic gain-of-function from polyglutamine expansion
Chromosomal Disorders
Trisomy distinguishing features, Turner vs Klinefelter hormone profiles, and 22q11.2 deletion variable expression.
- Confuses trisomy 13 (midline defects, polydactyly) with trisomy 18 (clenched fists, rocker-bottom feet)
- Predicts low gonadotropins in Turner syndrome, confusing primary ovarian failure with hypothalamic-pituitary dysfunction
Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu)
Autosomal dominant ENG/ALK1 mutations cause AVMs that enable paradoxical embolism and high-output cardiac failure.
- Misclassifies HHT as X-linked rather than autosomal dominant with ENG/ALK1 mutations
- Missing that pulmonary AVMs in HHT enable paradoxical embolism and brain abscess by bypassing the pulmonary capillary bed
Fat-Soluble Vitamins (A, D, E, K)
Vitamins A, D, E, K functions and toxicities, including which clotting test rises first in K deficiency.
- Assumes vitamin K deficiency affects all clotting factors equally, missing that factor VII's short half-life makes PT the first test to rise
- Attributes pseudotumor cerebri to vitamin A deficiency rather than vitamin A toxicity
Water-Soluble Vitamins (B-complex and C)
Thiamine-dependent enzymes, pellagra causes beyond diet, and why subacute combined degeneration is B12-specific, not folate.
- Knows PDH requires thiamine but misses alpha-ketoglutarate dehydrogenase and transketolase as equally tested thiamine-dependent enzymes
- Attributes neurological symptoms (subacute combined degeneration) to folate deficiency rather than exclusively to B12 deficiency
Minerals (Zinc, Copper, Iron, Selenium, Iodine)
Copper-dependent enzymes, Wilson vs Menkes mechanism distinction, and zinc deficiency clinical features.
- Confuses zinc deficiency features with iron deficiency anemia
- Confuses copper-dependent enzymes with zinc-dependent enzymes
Protein-Energy Malnutrition
Kwashiorkor edema from hypoalbuminemia vs marasmus, and refeeding syndrome's critical hypophosphatemia shift.
- Misattributes kwashiorkor edema to sodium retention rather than hypoalbuminemia
- Incorrectly attributes fatty liver to marasmus rather than kwashiorkor
Carbohydrate Structure and Digestion
Aldose vs ketose classification, lactase deficiency osmotic mechanism, and sucrose vs lactose composition.
- Confuses aldose/ketose classification (carbonyl position) with carbon count naming
- Overgeneralizes lactase deficiency to all carbohydrate malabsorption rather than lactose-specific osmotic diarrhea
Glycolysis (Pathway and ATP Yield)
Net 2 ATP from glycolysis, hexokinase vs glucokinase kinetics, and pyruvate kinase deficiency hemolytic anemia.
- Confuses gross ATP yield (4) with net ATP yield (2) in glycolysis
- Confuses hexokinase (first step) with PFK-1 (rate-limiting step) of glycolysis
Glycolysis Regulation (PFK-1 and Friends)
PFK-1 allosteric control by ATP, AMP, citrate, and F2,6BP from the bifunctional PFK-2/FBPase-2 enzyme.
- Confuses ATP's role as a PFK-1 substrate with its allosteric inhibitory effect on PFK-1
- Conflates hexokinase's product inhibition with PFK-1's role as the rate-limiting glycolytic enzyme
Fermentation and NAD+ Regeneration
LDH regenerates NAD+ to sustain glycolysis, with Cori cycle shuttling lactate to liver for gluconeogenesis.
- Misidentifies lactate production as the goal of LDH rather than NAD+ regeneration
- Incorrectly assigns gluconeogenesis in the Cori cycle to muscle rather than liver
Pyruvate Fates (Including PDH)
Four pyruvate fates by metabolic state, five PDH cofactors, and why PDH deficiency demands a ketogenic diet.
- Confuses PDH deficiency treatment (ketogenic diet) with glucose supplementation
- Misassigns pyruvate carboxylase activity to the fed state rather than the fasting/gluconeogenic state
TCA (Krebs) Cycle
TCA cycle yield, regulated enzymes, and allosteric inhibition by high ATP distinguishing entry from rate-limiting steps.
- Confuses TCA cycle yield per turn with yield per glucose molecule
- Confuses citrate synthase (entry step) with isocitrate dehydrogenase (regulatory step) in the TCA cycle
Electron Transport Chain and Oxidative Phosphorylation
Complexes I–V sequence, proton pumping assignments, inhibitor targets, and why uncouplers decrease ATP despite increasing oxygen consumption.
- Incorrectly assigns proton pumping to Complex II, which does not pump protons
- Conflates the primary mechanism of CO toxicity (hemoglobin binding) with cyanide's direct Complex IV inhibition
Gluconeogenesis
Four bypass enzymes with compartment locations, valid precursors, and why muscle cannot contribute to blood glucose.
- Incorrectly assigns gluconeogenesis capability to skeletal muscle, which lacks glucose-6-phosphatase
- Incorrectly classifies even-chain fatty acids as gluconeogenic precursors
Pentose Phosphate Pathway (PPP / HMP Shunt)
NADPH and ribose-5-phosphate production, G6PD deficiency oxidative triggers, and respiratory burst distinction from CGD.
- Confuses NADPH produced by PPP with NADH produced by glycolysis
- Misses that G6PD hemolysis requires an oxidative trigger, not baseline disease
Glycogen Metabolism
Synthesis and breakdown enzyme specificity, hormonal control logic, and Pompe as a lysosomal rather than cytoplasmic defect.
- Reverses glucagon's effect on glycogen synthase vs phosphorylase
- Misses that muscle glycogen cannot contribute to blood glucose due to absent glucose-6-phosphatase
Fatty Acid Oxidation (β-Oxidation)
Carnitine shuttle entry, malonyl-CoA inhibition of CPT-I, MCAD hypoketotic hypoglycemia, and why liver cannot use ketones.
- Reverses malonyl-CoA's inhibitory role — it inhibits beta-oxidation (via CPT-I), not synthesis
- Incorrectly believes the liver can oxidize the ketone bodies it synthesizes
Fatty Acid Synthesis
Cytoplasmic acetyl-CoA carboxylase is the rate-limiting step, with insulin driving reciprocal suppression of beta-oxidation.
- Confuses the cytoplasmic location of FA synthesis with the mitochondrial location of beta-oxidation
- Confuses HMG-CoA reductase (cholesterol synthesis RLS) with acetyl-CoA carboxylase (FA synthesis RLS)
Cholesterol Synthesis and Lipoprotein Transport
HMG-CoA reductase statin target, lipoprotein transport functions, LPL vs hepatic lipase substrates, and familial hypercholesterolemia receptor defect.
- Misidentifies the statin target as an earlier step rather than HMG-CoA reductase specifically
- Attributes familial hypercholesterolemia to LDL overproduction rather than defective LDL receptor uptake
Urea Cycle and Ammonia Disposal
OTC deficiency elevates orotic acid and ammonia together, distinguishing it from CPS I and hereditary orotic aciduria.
- Confuses elevated orotic acid in OTC deficiency with hereditary orotic aciduria without checking ammonia level
- Confuses OTC (most common deficiency) with CPS I (rate-limiting enzyme) of the urea cycle
Amino Acid Metabolism and Essential AAs
Essential amino acid recall, glucogenic vs ketogenic classification, and B6 as the ALT/AST transamination cofactor.
- Confuses MSUD enzyme defect (branched-chain alpha-ketoacid dehydrogenase) with phenylalanine hydroxylase defect in PKU
- Cannot cold-recall the distinguishing features of homocystinuria without clinical clues in the stem
Phenylketonuria (PKU) and Related Disorders
PAH defect, phenylalanine restriction rationale, and lens dislocation direction distinguishing homocystinuria from Marfan syndrome.
- Confuses lens dislocation direction: downward in homocystinuria vs upward in Marfan syndrome
- Confuses albinism (tyrosinase defect) with PKU (phenylalanine hydroxylase defect) in the phenylalanine/tyrosine pathway
Heme Synthesis and Porphyrias
ALA synthase feedback control, AIP neurovisceral vs PCT cutaneous findings, and lead's two enzyme targets in heme synthesis.
- Confuses AIP (neurovisceral, no skin findings) with PCT (cutaneous blistering, no neurological symptoms)
- Misses that lead inhibits two heme synthesis enzymes: ALA dehydratase and ferrochelatase
Purine and Pyrimidine Metabolism
Ring-building strategy differences, HGPRT defect in Lesch-Nyhan, toxic deoxyadenosine in ADA-SCID, and allopurinol interactions.
- Confuses purine synthesis strategy (ring built on ribose) with pyrimidine synthesis (ring built first, then attached to ribose)
- Confuses Lesch-Nyhan (HGPRT deficiency) with ADA deficiency as the cause of purine salvage failure
Sphingolipid Storage Diseases
Enzyme defect and cell type for each storage disease, with Fabry's X-linked inheritance separating it from the rest.
- Confuses the enzyme defects of Tay-Sachs and Niemann-Pick disease
- Misidentifies the cell type responsible for Gaucher disease pathology
Mucopolysaccharidoses (Hurler, Hunter)
Hurler vs Hunter inheritance and corneal clouding distinction, with glycosaminoglycan accumulation distinguishing MPS from sphingolipidoses.
- Confuses the inheritance patterns of Hurler versus Hunter syndrome
- Incorrectly attributes corneal clouding to Hunter syndrome
Galactose and Fructose Disorders
Galactosemia enzyme severity tiers, hereditary fructose intolerance vs essential fructosuria, and reducing substance vs dipstick urine testing.
- Confuses the enzyme defect in classic galactosemia with galactokinase deficiency
- Conflates the severity and mechanism of essential fructosuria with hereditary fructose intolerance
Fed vs Fasted State Integration
Fed vs fasted metabolic priorities across liver, muscle, and adipose, including brain ketone use during prolonged starvation.
- Incorrectly believes the brain cannot use ketone bodies during prolonged starvation
- Assumes RBCs can utilize alternative fuels during fasting
Ethanol Metabolism
Aldehyde dehydrogenase is disulfiram's target, methanol toxicity comes from formate metabolites, and NADH excess impairs gluconeogenesis.
- Confuses disulfiram's enzyme target with alcohol dehydrogenase instead of aldehyde dehydrogenase
- Attributes methanol toxicity to the parent compound rather than its toxic metabolites
See how your Anki deck covers Biochemistry.
Upload your deck for a free audit →